Instadose Financial Statements From 2010 to 2025

INSD Stock  USD 0  0.00  0.00%   
Instadose Pharma financial statements provide useful quarterly and yearly information to potential Instadose Pharma Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Instadose Pharma financial statements helps investors assess Instadose Pharma's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Instadose Pharma's valuation are summarized below:
Market Capitalization
585.1 K
Earnings Share
(0.01)
There are over eighty-one available fundamental trends for Instadose Pharma Corp, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Instadose Pharma's regular performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. The current year's Enterprise Value is expected to grow to about 1.7 B, whereas Working Capital is projected to grow to (225.8 K).
Check Instadose Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Instadose Pharma's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 557.9 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 1.6 K, Days Sales Outstanding of 0.0 or Free Cash Flow Yield of 0.0. Instadose financial statements analysis is a perfect complement when working with Instadose Pharma Valuation or Volatility modules.
  
Check out the analysis of Instadose Pharma Correlation against competitors.

Instadose Pharma Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Current Liabilities196 K186.6 K81 K
Slightly volatile
Net Debt36.3 K64 K33.9 K
Slightly volatile
Accounts Payable93.7 K89.2 K36.6 K
Slightly volatile
Common Stock Shares Outstanding82.5 M86.3 M76.2 M
Slightly volatile
Total Liabilities196 K186.6 K81 K
Slightly volatile
Short and Long Term Debt36.8 K64 K34.4 K
Slightly volatile
Common Stock6.4 K6.8 K49.6 K
Slightly volatile
Other Current Liabilities70.2 K97.4 K56.6 K
Slightly volatile
Capital Stock8.2 K8.6 K65.5 K
Slightly volatile
Cash And Short Term Investments52.058.563.7813
Slightly volatile
Common Stock Total Equity6.4 K6.8 K49.6 K
Slightly volatile
Liabilities And Stockholders Equity52.058.563.7813
Slightly volatile

Instadose Pharma Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative557.9 K531.3 K202.2 K
Slightly volatile

Instadose Pharma Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings398380166
Slightly volatile
Other Non Cash Items464.5 K442.4 K161.6 K
Slightly volatile
Change To Netincome464.5 K442.4 K161.6 K
Slightly volatile
Change To Operating Activities55 K61.9 K67.5 K
Slightly volatile
Cash Flows Other Operating98.8 K176.5 K71.9 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.6 K1.8 KK
Slightly volatile
Average Payables5.3 KK2.6 K
Slightly volatile
EV To Sales1.6 K1.9 KK
Slightly volatile
Payables Turnover1.381.561.6999
Slightly volatile
Sales General And Administrative To Revenue7.338.258.9901
Slightly volatile
Cash Per Share0.00.00.0035
Slightly volatile
Days Payables Outstanding169190207
Slightly volatile
Current Ratio4.0E-45.0E-41.7304
Slightly volatile
Revenue Per Share0.00.00.0
Slightly volatile
Interest Debt Per Share8.0E-49.0E-40.001
Slightly volatile
Debt To Assets623594339
Slightly volatile
Days Of Payables Outstanding169190207
Slightly volatile
Ebt Per Ebit0.991.21.1738
Slightly volatile
Quick Ratio4.0E-45.0E-41.7304
Slightly volatile
Net Income Per E B T1.01.121.2241
Slightly volatile
Cash Ratio4.0E-45.0E-41.7304
Slightly volatile
Debt Ratio623594339
Slightly volatile
Price Sales Ratio1.6 K1.8 KK
Slightly volatile
Asset Turnover21.7224.4326.6406
Slightly volatile
Gross Profit Margin0.390.440.4818
Slightly volatile

Instadose Pharma Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.7 B1.7 B1.1 B
Slightly volatile
Enterprise Value1.7 B1.7 B676.2 M
Slightly volatile

About Instadose Pharma Financial Statements

Instadose Pharma stakeholders use historical fundamental indicators, such as Instadose Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Instadose Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Instadose Pharma's assets and liabilities are reflected in the revenues and expenses on Instadose Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Instadose Pharma Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sales General And Administrative To Revenue 8.25  7.33 
Ebit Per Revenue(5.88)(6.17)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Instadose Pharma Corp is a strong investment it is important to analyze Instadose Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instadose Pharma's future performance. For an informed investment choice regarding Instadose Stock, refer to the following important reports:
Check out the analysis of Instadose Pharma Correlation against competitors.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instadose Pharma. If investors know Instadose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instadose Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Return On Assets
(694.06)
The market value of Instadose Pharma Corp is measured differently than its book value, which is the value of Instadose that is recorded on the company's balance sheet. Investors also form their own opinion of Instadose Pharma's value that differs from its market value or its book value, called intrinsic value, which is Instadose Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instadose Pharma's market value can be influenced by many factors that don't directly affect Instadose Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instadose Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instadose Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instadose Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.